Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Diagnostic Imaging | | | | 13.9 | 11.9 | 12.1 | 13.9 | 14.4 |
Diagnostic Services | | | | | | 49.0 | 48.3 | 46.4 |
Other | | | | 59.1 | 92.3 | 43.5 | 63.3 | |
Total revenues [+] | 112.2 | 106.6 | 78.2 | 72.9 | 104.2 | 104.6 | 125.5 | 60.8 |
Products | | | | | | | 30.0 | 14.4 |
Services | | | | | | | 95.5 | 46.4 |
Revenue growth [+] | 5.2% | 36.3% | 7.2% | -30.0% | -0.4% | -16.6% | 106.3% | 9.4% |
Diagnostic Imaging | | | | 16.9% | -1.8% | -12.9% | -3.8% | 7.3% |
Diagnostic Services | | | | | | 1.5% | 4.1% | |
Cost of goods sold [+] | 86.3 | 91.3 | 64.2 | 55.8 | 85.9 | 83.4 | 89.7 | 42.9 |
Cost of product sales | | | | | | | 14.2 | 6.9 |
Cost of services | | | | | | | 75.5 | 36.0 |
Gross profit | 25.9 | 15.2 | 14.0 | 17.2 | 18.3 | 21.2 | 35.8 | 17.9 |
Gross margin | 23.1% | 14.3% | 17.9% | 23.5% | 17.5% | 20.3% | 28.5% | 29.4% |
Selling, general and administrative [+] | 27.3 | 22.6 | 18.6 | 15.9 | 20.5 | 24.8 | 30.0 | 14.6 |
Sales and marketing | 27.3 | 22.6 | 18.6 | 15.9 | 20.5 | 6.2 | 10.0 | 4.7 |
General and administrative | | | | | | 18.6 | 20.0 | 9.9 |
Research and development | | | | | | | | |
Other operating expenses | | | | | 0.5 | 1.5 | 2.3 | 0.5 |
EBITDA [+] | 0.4 | -5.6 | -2.8 | 2.9 | 3.3 | 2.8 | 13.3 | 5.2 |
EBITDA growth | -107.7% | 97.8% | -199.0% | -12.2% | 17.8% | -79.2% | 155.3% | 1.4% |
EBITDA margin | 0.4% | -5.3% | -3.6% | 3.9% | 3.1% | 2.6% | 10.6% | 8.6% |
Depreciation | 1.8 | 1.7 | 1.8 | 1.6 | 6.0 | 6.4 | 7.6 | 1.9 |
EBITA | -1.4 | -7.4 | -4.6 | 1.3 | -2.7 | -3.6 | 5.7 | 3.3 |
EBITA margin | -1.2% | -6.9% | -5.9% | 1.7% | -2.6% | -3.5% | 4.6% | 5.4% |
Amortization of intangibles | 1.7 | 1.7 | 2.1 | 0.8 | 1.4 | 1.5 | 2.3 | 0.5 |
EBIT [+] | -3.1 | -9.1 | -6.8 | 0.4 | -4.1 | -5.1 | 3.4 | 2.8 |
EBIT growth | -65.8% | 34.1% | -1664.0% | -110.6% | -20.7% | -250.0% | 23.4% | -13.6% |
EBIT margin | -2.8% | -8.5% | -8.7% | 0.6% | -3.9% | -4.9% | 2.7% | 4.6% |
Non-recurring items [+] | | 2.5 | 0.4 | 2.3 | 0.5 | 0.2 | 0.3 | |
Asset impairment | | 3.4 | 0.4 | | 0.5 | 0.2 | 0.3 | |
Interest expense | 1.0 | 0.9 | 1.3 | 0.7 | 0.8 | 0.7 | | |
Interest expense | 1.0 | 0.9 | 1.3 | 0.7 | 0.8 | 0.7 | | |
Other income (expense), net [+] | -1.0 | 3.6 | 3.3 | -0.3 | -0.1 | -1.0 | -1.2 | -0.3 |
Gain (loss) on sale of assets | | | | | 0.5 | | | |
Gain (loss) on debt retirement | | | | -0.2 | 0.0 | -0.7 | | |
Other | -1.0 | -0.6 | 3.3 | -0.1 | -0.1 | -0.3 | | |
Pre-tax income | -5.1 | -8.9 | -5.2 | -2.9 | -5.4 | -7.0 | 1.9 | 2.5 |
Income taxes | 0.2 | 0.1 | 0.1 | -0.2 | -1.6 | 28.0 | -12.4 | -19.1 |
Tax rate | | | | 6.8% | 28.9% | | | |
Net income | -7.2 | -4.9 | -8.4 | -5.2 | 0.7 | -35.7 | 14.3 | 21.6 |
Net margin | -6.4% | -4.6% | -10.7% | -7.2% | 0.7% | -34.1% | 11.4% | 35.6% |
|
Basic EPS [+] | ($0.49) | ($0.96) | ($2.29) | ($2.56) | $0.37 | ($1.75) | $0.73 | $1.13 |
Growth | -49.5% | -58.0% | -10.6% | -801.0% | -120.8% | -340.1% | -35.2% | 745.3% |
Diluted EPS [+] | ($0.49) | ($0.96) | ($2.29) | ($2.56) | $0.37 | ($1.75) | $0.71 | $1.10 |
Growth | -49.5% | -58.0% | -10.6% | -801.0% | -120.8% | -345.9% | -35.2% | 738.3% |
|
Dividends per share [+] | | | ($0.52) | ($0.29) | $1.65 | $0.21 | $0.20 | $0.20 |
Growth | | -100.0% | 79.3% | -117.6% | 685.7% | 5.0% | 0.0% | 0.0% |
|
Shares outstanding (basic) [+] | 14.8 | 5.1 | 3.7 | 2.0 | 2.0 | 20.0 | 19.6 | 19.2 |
Growth | 190.1% | 39.0% | 79.3% | 1.2% | -89.9% | 2.0% | 2.0% | 3.4% |
Shares outstanding (diluted) [+] | 14.8 | 5.1 | 3.7 | 2.0 | 2.0 | 20.0 | 20.1 | 19.7 |
Growth | 190.1% | 39.0% | 79.3% | 1.2% | -89.9% | -0.4% | 1.9% | 4.3% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|